drugset / Trial / NCT00833937

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

NCT00833937

Phase 1 Completed 24 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the relative bioavailability of Zolpidem tartrate 10 mg tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA Pharmaceuticals USA) with that of AMBIEN® tablets(G.D. Searle \& Co.) in healthy, adult, non-smoking subjects under non-fasting conditions.

Timeline

Start
2002-03
Primary completion
2002-03
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 10 mg

Indications

No indication recorded.